Cargando…

Effect of Angiogenesis Inhibitor Bevacizumab on Survival in Patients with Cancer: A Meta-Analysis of the Published Literature

Bevacizumab is a recombinant humanized monoclonal antibody against vascular endothelial growth factor which has been used in conjunction with other anti-cancer agents in the treatment of patients with many cancers. It remains controversial whether bevacizumab can prolong survival in cancer patients....

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Yuan, Yang, Wei-Bing, Li, Shi, Ye, Zhi-Jian, Shi, Huan-Zhong, Zhou, Qiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335091/ https://www.ncbi.nlm.nih.gov/pubmed/22539986 http://dx.doi.org/10.1371/journal.pone.0035629

Ejemplares similares

Angiogenesis Inhibitor Bevacizumab Increases the Risk of Ischemic Heart Disease Associated with Chemotherapy: A Meta-Analysis
por: Chen, Xing-Lin, et al.
Publicado: (2013)

Inhibition of Angiogenesis and Extracellular Matrix Remodeling: Synergistic Effect of Renin-Angiotensin System Inhibitors and Bevacizumab
por: Ren, Tianshu, et al.
Publicado: (2022)

Platelet function is disturbed by the angiogenesis inhibitors sunitinib and sorafenib, but unaffected by bevacizumab
por: Walraven, Maudy, et al.
Publicado: (2018)

A Novel Angiogenesis Inhibitor Bevacizumab Induces Apoptosis in the Rat Endometriosis Model
por: Soysal, D, et al.
Publicado: (2015)

Neoadjuvant Therapy of Cervical Carcinoma with the Angiogenesis Inhibitor Bevacizumab: a Single-Centre Analysis
por: Junker, Philip, et al.
Publicado: (2018)

The impact of angiogenesis inhibitors on survival of patients with small cell lung cancer
por: Shi, Xiaoshun, et al.
Publicado: (2019)

Angiogenesis-related protein expression in bevacizumab-treated metastatic colorectal cancer: NOTCH1 detrimental to overall survival
por: Paiva, Tadeu Ferreira, et al.
Publicado: (2015)

A novel method of screening combinations of angiostatics identifies bevacizumab and temsirolimus as synergistic inhibitors of glioma-induced angiogenesis
por: Dorrell, Michael I., et al.
Publicado: (2021)

Publisher Correction: High mitogenic stimulation arrests angiogenesis
por: Pontes-Quero, Samuel, et al.
Publicado: (2019)

Hidradenitis Suppurativa and JAK Inhibitors: A Review of the Published Literature
por: Martora, Fabrizio, et al.
Publicado: (2023)

Genetic Modification of Neurons to Express Bevacizumab for Local Anti-angiogenesis Treatment of Glioblastoma
por: Hicks, Martin J., et al.
Publicado: (2014)

Comparison of Bevacizumab and Aflibercept for Suppression of Angiogenesis in Human Retinal Microvascular Endothelial Cells
por: Yazdanyar, Amirfarbod, et al.
Publicado: (2023)

Effect of Intravitreal Bevacizumab with or without Macular Photocoagulation for Diabetic Macular Edema: A Meta-Analysis
por: Xiao, Kang, et al.
Publicado: (2018)

Differentiation and Recruitment of Th9 Cells Stimulated by Pleural Mesothelial Cells in Human Mycobacterium tuberculosis Infection
por: Ye, Zhi-Jian, et al.
Publicado: (2012)

Bevacizumab in recurrent glioblastoma
por: Martinez, Nina L., et al.
Publicado: (2019)

Efficacy and Safety of Talc Pleurodesis for Malignant Pleural Effusion: A Meta-Analysis
por: Xia, Huan, et al.
Publicado: (2014)

Genetic Variants on Chromosome 8q24 and Colorectal Neoplasia Risk: A Case-Control Study in China and a Meta-Analysis of the Published Literature
por: Li, Mian, et al.
Publicado: (2011)

Published patterns of spin in biomedical literature: a protocol for a meta-research study
por: Su, Naichuan, et al.
Publicado: (2021)

Editorial: Angiogenesis and Angiogenesis Inhibitors in Oral Cancer
por: Salem, Abdelhakim, et al.
Publicado: (2021)

The Impact of Bevacizumab (Avastin) on Survival in Metastatic Solid Tumors - A Meta-Analysis and Systematic Review
por: Amit, Limor, et al.
Publicado: (2013)

Efficacy and safety of anlotinib, a multikinase angiogenesis inhibitor, in combination with epirubicin in preclinical models of soft tissue sarcoma
por: Wang, Zhi‐Ming, et al.
Publicado: (2020)

The prevalence and heterogeneity of prehypertension: a meta-analysis and meta-regression of published literature worldwide
por: Guo, X, et al.
Publicado: (2012)

Survival benefit and safety of the combinations of FOLFOXIRI ± bevacizumab versus the combinations of FOLFIRI ± bevacizumab as first-line treatment for unresectable metastatic colorectal cancer: a meta-analysis
por: Xu, Wei, et al.
Publicado: (2016)

Re-irradiation combined with bevacizumab for recurrent glioblastoma beyond bevacizumab failure: survival outcomes and prognostic factors
por: You, Weir-Chiang, et al.
Publicado: (2023)

Combination of Ad-SGE-REIC and bevacizumab modulates glioma progression by suppressing tumor invasion and angiogenesis
por: Hattori, Yasuhiko, et al.
Publicado: (2022)

Bevacizumab-Controlled Delivery from Polymeric Microparticle Systems as Interesting Tools for Pathologic Angiogenesis Diseases
por: De Negri Atanasio, Giulia, et al.
Publicado: (2022)

Angiogenesis Inhibitors in NSCLC
por: Manzo, Anna, et al.
Publicado: (2017)

A Phase I/II Study Targeting Angiogenesis Using Bevacizumab Combined with Chemotherapy and a Histone Deacetylase Inhibitor (Valproic Acid) in Advanced Sarcomas
por: Monga, Varun, et al.
Publicado: (2018)

The integration of bevacizumab improves tumor response and survival in patients with refractory cervical cancer treated with radical chemoradiotherapy
por: Yang, Hua, et al.
Publicado: (2021)

Correction: The Impact of Bevacizumab (Avastin) on Survival in Metastatic Solid Tumors - A Meta-Analysis and Systematic Review
por: Amit, Limor, et al.
Publicado: (2013)

Bevacizumab Combined with Chemotherapy Improves Survival for Patients with Metastatic Colorectal Cancer: Evidence from Meta Analysis
por: Ilic, Irena, et al.
Publicado: (2016)

Bevacizumab improves survival in metastatic colorectal cancer patients with primary tumor resection: A meta-analysis
por: Cao, Dedong, et al.
Publicado: (2019)

CD39(+ )Regulatory T cells suppress generation and differentiation of Th17 cells in human malignant pleural effusion via a LAP-dependent mechanism
por: Ye, Zhi-Jian, et al.
Publicado: (2011)

A systematic review and meta-analysis on the effect of angiogenesis blockade for the treatment of gastric cancer
por: Bai, Zhi-Gang, et al.
Publicado: (2018)

Efficacy and Safety Analysis of Immune Checkpoint Inhibitors plus Angiogenesis Inhibitors for the Treatment of Advanced Driver-negative NSCLC in Elderly Patients: A Retrospective Study
por: Zhang, Jian, et al.
Publicado: (2023)

Successful regression of newly formed corneal neovascularization by subconjunctival injection of bevacizumab in patients with chemical burns
por: Peng, Wen-yan, et al.
Publicado: (2023)

For or against Adjuvant Trastuzumab for pT1a-bN0M0 Breast Cancer Patients with HER2-Positive Tumors: A Meta-Analysis of Published Literatures
por: Zhou, Qiong, et al.
Publicado: (2014)

Cell Origins and Diagnostic Accuracy of Interleukin 27 in Pleural Effusions
por: Yang, Wei-Bing, et al.
Publicado: (2012)

Genetic Variants in the Folate Pathway and the Risk of Neural Tube Defects: A Meta-Analysis of the Published Literature
por: Zhang, Ti, et al.
Publicado: (2013)

Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues
por: Zhuang, Hongqing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1fn53iug1k2kmc0gq6ph3go6gp